Furth C - Search Results

1

68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer.

Kalinauskaite G, Senger C, Kluge A, Furth C, Kufeld M, Tinhofer I, Budach V, Beck M, Hochreiter A, Grün A, Stromberger C. Kalinauskaite G, et al. Among authors: furth c. PLoS One. 2020 Oct 21;15(10):e0240892. doi: 10.1371/journal.pone.0240892. eCollection 2020. PLoS One. 2020. PMID: 33085712 Free PMC article.

2

Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.

Zschaeck S, Wust P, Beck M, Wlodarczyk W, Kaul D, Rogasch J, Budach V, Furth C, Ghadjar P. Zschaeck S, et al. Among authors: furth c. Radiat Oncol. 2017 Aug 23;12(1):140. doi: 10.1186/s13014-017-0877-x. Radiat Oncol. 2017. PMID: 28830532 Free PMC article.

3

Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma.

Li Y, Hofheinz F, Furth C, Lili C, Hua W, Ghadjar P, Zschaeck S. Li Y, et al. Among authors: furth c. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1752-1761. doi: 10.1007/s00259-018-3996-1. Epub 2018 Apr 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29679113

4

⁶⁸ Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer.

Damjanovic J, Janssen JC, Furth C, Diederichs G, Walter T, Amthauer H, Makowski MR. Damjanovic J, et al. Among authors: furth c. Cancer Imaging. 2018 May 16;18(1):20. doi: 10.1186/s40644-018-0154-8. Cancer Imaging. 2018. PMID: 29769114 Free PMC article.

5

Ga-68-PSMA PET/CT in treatment-naïve patients with prostate cancer: Which clinical parameters and risk stratification systems best predict PSMA-positive metastases?

Rogasch JM, Cash H, Zschaeck S, Elezkurtaj S, Brenner W, Hamm B, Makowski M, Amthauer H, Furth C, Baur ADJ. Rogasch JM, et al. Among authors: furth c. Prostate. 2018 Jul 5. doi: 10.1002/pros.23685. Online ahead of print. Prostate. 2018. PMID: 29978529

6

Prostate-Specific Membrane Antigen-Positive Manifestations of Chronic Beryllium Lung Disease.

Huang K, Baur AD, Furth C. Huang K, et al. Among authors: furth c. Clin Nucl Med. 2019 Jan;44(1):64-65. doi: 10.1097/RLU.0000000000002323. Clin Nucl Med. 2019. PMID: 30358624

7

Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients.

Frost N, Tessmer A, Schmittel A, van Laak V, Raspe M, Ruwwe-Glösenkamp C, Brunn M, Senger C, Böhmer D, Ochsenreither S, Temmesfeld-Wollbrück B, Furth C, Schmidt B, Neudecker J, Rückert JC, Suttorp N, Witzenrath M, Grohé C. Frost N, et al. Among authors: furth c. Lung Cancer. 2018 Nov;125:164-173. doi: 10.1016/j.lungcan.2018.09.021. Epub 2018 Sep 25. Lung Cancer. 2018. PMID: 30429016

8

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE.

Wetz C, Genseke P, Apostolova I, Furth C, Ghazzawi S, Rogasch JMM, Schatka I, Kreissl MC, Hofheinz F, Grosser OS, Amthauer H. Wetz C, et al. Among authors: furth c. PLoS One. 2019 May 15;14(5):e0216781. doi: 10.1371/journal.pone.0216781. eCollection 2019. PLoS One. 2019. PMID: 31091247 Free PMC article. Clinical Trial.

9

Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.

Acker G, Kluge A, Lukas M, Conti A, Pasemann D, Meinert F, Anh Nguyen PT, Jelgersma C, Loebel F, Budach V, Vajkoczy P, Furth C, Baur ADJ, Senger C. Acker G, et al. Among authors: furth c. Neurosurg Focus. 2019 Jun 1;46(6):E9. doi: 10.3171/2019.3.FOCUS1925. Neurosurg Focus. 2019. PMID: 31153151

10

Validation of Independent Prognostic Value of Asphericity of ¹⁸F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent.

Rogasch JMM, Furth C, Chibolela C, Hofheinz F, Ochsenreither S, Rückert JC, Neudecker J, Böhmer D, von Laffert M, Amthauer H, Frost N. Rogasch JMM, et al. Among authors: furth c. Clin Lung Cancer. 2020 May;21(3):264-272.e6. doi: 10.1016/j.cllc.2019.10.001. Epub 2019 Oct 15. Clin Lung Cancer. 2020. PMID: 31839531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page